NPI | Name | Type | Address |
---|---|---|---|
PHARMD, BCOP Connor Roth |
Individual |
3900 W 203rd St Olympia Fields, IL |
|
PHARMD Talha Shahid Khan |
Individual |
251 E Huron St Chicago, IL |
|
DR. PHARMD Alisa Muckalli |
Individual |
902 Quentin Rd Fl Pharmacy Brooklyn, NY |
|
PHARMD Mohammad Hasibur Rahman |
Individual |
1700 6th Ave S Birmingham, AL |
|
PHARMD Piper Laurie Lamonica |
Individual |
23 Sutton Pl N Moorestown, NJ |
|
PHARMD Phuong Cham T Nguyen |
Individual |
1825 4th St Rm M3262 San Francisco, CA |
|
PHARMD Bartholomew Lino |
Individual |
2884 N Highway 17 Mount Pleasant, SC |
|
PHARMD Jamie Dupuie |
Individual |
145 Michigan St Ne Ste 3100 Grand Rapids, MI |
|
PHARM.D. Diana Van Ostran |
Individual |
8900 N Kendall Dr Miami, FL |
|
PHARMD Mayret Gonzalez |
Individual |
8900 N Kendall Dr Miami, FL |
|
Alyson Leonard |
Individual |
1236 Huffman Mill Rd Ste 120 Burlington, NC |
|
PHARMD Stephanie Nicole Schneck |
Individual |
535 Barnhill Dr Indianapolis, IN |
|
DR. PHARMD Andy Jeon |
Individual |
160 E 53rd St New York, NY |
|
PHARMD, BCOP Jameson B Wood |
Individual |
150 S Huntington Ave Boston, MA |
|
Scott Heinemann |
Individual |
550 University Blvd Indianapolis, IN |
|
PHARMD Brian Gregory Bazzell |
Individual |
2215 Fuller Rd Ann Arbor, MI |
|
PHARMD Sarah Fillman |
Individual |
420 S 5th Ave Reading, PA |
|
PHARMD Amy Goodpaster |
Individual |
2508 Myrtle St Erie, PA |
|
David Hughes |
Individual |
830 Harrison Ave Fl 3 Boston, MA |
|
PHARMD Jasmine Patel |
Individual |
830 Harrison Ave Bldg 3 Boston, MA |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
Taxonomy Code | 1835X0200X |
Specialization | Oncology |
Display Name | Oncology Pharmacist |
Taxonomy Group | Pharmacy Service Providers |
Taxonomy Classification | Pharmacist |
Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
Effective Date | September 30, 2009 |